title: Cocaine use by schizophrenic outpatients who receive depot neuroleptic medication.
authors.affiliation: Philadelphia Veterans Affairs Medical Center, Pennsylvania.
authors.forename: A M
authors.initials: AM
authors.lastname: Stone
authors.forename: R A
authors.initials: RA
authors.lastname: Greenstein
authors.forename: G
authors.initials: G
authors.lastname: Gamble
authors.forename: A T
authors.initials: AT
authors.lastname: McLellan
mesh_terms: D000328:Adult; D000553:Ambulatory Care; D002908:Chronic Disease; D003042:Cocaine; D003131:Combined Modality Therapy; D015897:Comorbidity; D003692:Delayed-Action Preparations; D005476:Fluphenazine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006220:Haloperidol / Q000627:therapeutic use*; D006801:Humans; D007273:Injections, Intramuscular; D008875:Middle Aged; D012559:Schizophrenia / Q000534:rehabilitation*; D012565:Schizophrenic Psychology; D015813:Substance Abuse Detection; D019966:Substance-Related Disorders / Q000523:psychology / Q000534:rehabilitation*; D014728:Veterans / Q000523:psychology*
chemical_list: D003692:Delayed-Action Preparations; C011825:fluphenazine depot; D003042:Cocaine; D006220:Haloperidol; D005476:Fluphenazine